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Background
The role that neutralizing antibodies (NAbs) play in con-
trolling viral replication during early HIV infection is not
fully understood. Autologous HIV NAbs are first detected
in humans several weeks after peak viremia, suggesting
that they are not involved in the initial decrease in viral
load. However, it is not clear if these antibodies are
present at titers lower than the limit of detection of cur-
rent assays. To more clearly evaluate this question, we
have investigated the development of NAbs in early SIV
infection using the macaque model system.
Methods
Six macaques were infected with SIVmac251 via repeated
vaginal exposures. Three were exposed to a plasma pool
derived from animals infected for 1–6 wks, and three were
exposed to a plasma pool from animals infected for 16
wks. SIV envelope genes were amplified from longitudinal
plasma samples by RT-PCR. Pseudotyped virions were
produced using a replication-defective retroviral vector
containing a luciferase gene. The ability of plasma anti-
bodies to neutralize pseudotyped virions was assessed by
measuring luciferase activity 72 hrs after viral inoculation.
Results
High-titer heterologous NAb activity was detected in each
of the infected macaques. Nabs were detected as early as
peak viremia in 2/6 animals, and increased with time in
all 6 animals. NAb activity against contemporary autolo-
gous viral isolates was detected in 5/6 animals, with the
earliest detection at peak viremia in 1/5 animals. Evidence
of viral escape from contemporaneous autologous NAbs
was detected in 2/5 animals.
Conclusion
Autologous NAb activity was detected in some SIV-
infected macaques up to 10 wks earlier than typically
found in HIV-infected humans, and antibody titers were
an average of 10 fold greater. The detection of autologous
NAb activity and subsequent viral escape during the early
stages of infection suggests that NAbs may be playing a
role in the initial control of viral replication in SIV infec-
tion.
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